Pierre-Yves Brossard

"What's new in healthcare innovation globally?" I had the pleasure to share my thoughts on this topic at the annual event in Paris hosted by La Poste Santé & Autonomie, which brought together the entire French #healthcare and #healthTech ecosystem. Thank you florence dupre and Olivier Barets for the invitation, and appreciation to my fellow panelists: . François BRAUN: Former Minister of Social Affairs and Health of #France . stephane pierrefitte: Deputy General Director at the University Hospital Group (Psychiatry & Neurosciences) . Hélène GUIMIOT: Head of the Health Service in the Legal Support Department of the French data protection authority (CNIL) . Kathy Malas: Director of Research, Innovation, and Learning at CISSS Montérégie-Ouest, Quebec. Special thanks to Dominique Pon, CEO of La Poste Santé & Autonomie for the great moderation (and great event). The key points of my presentations in a nutshell: The NHS, a cornerstone of British pride, is in crisis according to Lord Darzi's 2024 report (published in Sep 24) Key findings show 33% of Britons now wait over a week for GP appointments, compared to 16% in 2021. Bupa has responded by offering a subscription model for primary care: £17/month for same-day teleconsultations or £22/month for in-person visits, raising concerns about a potential two-tier system. Following the publication of the report, UK Prime Minister Sir Keir Starmer aims to transition the NHS to a digital system. There are already promising initiatives within the NHS like the 42 Integrated Care Systems (ICS) and the GP Practice Improvement Program, which has replaced 30% of face-to-face visits with text consultations. AI could also play a crucial role, with most NHS staff supporting its use in patient care (76%) and administration (81%). Four key #AI archetypes include: 1️⃣ Non-clinical AI for consumers/patients AI-based care navigation, seen with US companies like Transcarent or UnitedHealth Group's Find Care & Costs tool. 2️⃣ Clinical AI for consumers/patients AI predictive models intercepting disease through blood analysis (e.g., Function Health, Aware) or imaging (e.g., Neko Health). 3️⃣ Clinical AI for health professionals AI Clinical Decision Support (AI-CDS), especially in radiology (75% of FDA approved AI-CDS), but also beyond with companies like Tempus AI in AI-oncology. 4️⃣ Non-clinical AI for healthcare professionals AI-enhanced administrative management (like Ambient AI, ...), likely to see the fastest adoption in the short term. Three potential winners in the AI healthcare transformation: Epic: Aiming to orchestrate AI in hospitals with its App Store Showroom. Mayo Clinic: Already using 70+ AI algorithms and developing the Mayo Clinic Platform_Connect, a data hub connecting major hospitals for AI model training. La Poste Santé & Autonomie: An innovative public player acting as a trusted intermediary between healthcare systems, industry, and regulators to implement new models of care.

147

7 commentaires

Thank you again #Nobel Prize Laureate Jean Tirole & Pierre Dubois for a thought-provoking Health Economics Conference at Toulouse School of Economics last month! ❣ Happy to share that the replay 📹 of our panel on the use of Health Data, Platforms & Digital Technologies for Innovation is now available 👇 The panel was chaired by Jean Tirole, with Edwin Morley-Fletcher & Ariel Dora Stern 👉 I was happy to present Dassault Systèmes' ambition in #LifeSciences & #Healthcare, and how #VirtualTwin can accelerate therapeutic innovation and improve medical practice. Among examples shared, I mentioned #SCA (synthetic control arms), #MediTwin, our partnership with FDA for in silico clinical trials. Edwin Morley-Fletcher shared the ambition of European Commission to build a common platform for Human Virtual Twins and the role played by #EDITH consortium to create standards. Ariel Dora Stern shared meaningful examples of the use of #AI and #GenAI in drug discovery as well as medical practice. The ⁉ Q&A ⁉ session was quite stimulating, thank you 🙏 to the passionate attendees in the audience! 🌩 Key challenges ahead of us include: 1️⃣ Access to data, which itself requires a solid business model, data standardization, trusted Cloud 2️⃣ Reimbursement & adoption in physicians workflow -> change management will be key

27

Looking forward to sharing my perspectives and hearing how others are approaching the global VC landscape at this session at #GRIC2024!

19

Speaking with President Macron in New York yesterday during UN General Assembly week, we emphasized France's outsized role in the innovation economy. General Catalyst has invested over $500Mn in leading startups in the country like Mistral AI and Shift Technology, and I have seen myself the talent density especially in AI through organizations like STATION F. The French have immense opportunity to lead in AI by promoting a competitive landscape—engaging incumbents while promoting home grown startups and allowing startups to thrive without a burdensome regulatory scheme. Their leadership in advanced energy through nuclear power will not only support the AI revolution domestically, but can be exported to allied countries around the world which we desperately need.  As my partner and Head of GC Europe Jeannette zu Fürstenberg says, we believe Europe should have the ambition to create 3 of the 10 largest global tech companies. Between France and other leading European countries, with a set of balanced policies that allow European tech companies to grow, this is possible. At GC we are partnering with policymakers to build towards that ambition. #UNGA Cc: Teresa Carlson Maryam Mujica Chris Bischoff Alexandre Momeni

219

6 commentaires

Curious about the intersection of health innovation and venture capital? Don’t miss this episode featuring Anne-Sophie Saint-Martin, Partner at Newfund, as she shares her journey and insights on investing in health startups and launching a fund dedicated to brain startups. In this podcast, you’ll discover: ✅ Anne-Sophie’s unique background and what drives her passion for health investments. ✅ Why health tech is a unique and complex investment field, often overlooked for this very reason, yet incredibly compelling both for its societal impact and its financial performance potential. ✅ How this focus perfectly aligns with Newfund’s mission of bridging Europe and the U.S. since its launch in 2008. Newfund continues to champion bold ideas and international synergies across markets. Tune in to learn how we’re shaping the future of health and innovation on both sides of the Atlantic! 🌎✨ 🎧 Listen now: https://lnkd.in/ei_2ZY2E Thx Benjamin WATTINNE for this great podcast series! #VentureCapital #HealthTech #BrainHealth #Innovation #Startups #Europe #USA #HekaFund

34

2 commentaires

By what means can we describe the universe, at the level of the infinitely small and the infinitely large including the 4 fundamental forces that govern the universe 🤔 ? 📗The answer is simple thanks to the infinitesimal unit wave vector of the released photon as described in kenitic theory by Dr. Feynman ( رحمه الله) in chapter 39_3 of compressibility of radiation ✍🏼.

1

5 commentaires

how brillant! At #OrphanHealthcare, we've just kicked open the doors to an new opportunity that's as big as the free pizza at a startup launch! We’re getting a new office at the end of summer and offering a great, still free 120 sqm of ultra-modern office space for your, absolutely amazing! And trust me, this isn't your average, everyday office space at the edge of Zurich. It combines work and work-life balance. 😍 Here’s the Scoop on the Space: 🖐🏻 If size Matters: A whopping 350 sqm of chic, open-plan office space begging you to throw some desks and dreams into it. And 120 sqm are still available for you. 🛀🏻 Design & Comfort: It’s got everything – 2 snazzy meeting rooms for when you need to impress, a lounge for lounging (obviously), an open kitchen to test your cooking show fantasies, and even an event spot for your TEDx rehearsal. 🤓 Tech Ready: All the state-of-the-art fixings to make sure you can tweet faster, work smarter, and Netflix chill harder. ⛳ Location, Location, Location: Right on the nerve center of everything cool - next to trams, trains, and an expressway to pretty much everywhere. 🚀 Why You’ll Love It: Price Tag. It’s about amazing for the prices others pay in downtown Zurich. Flex Appeal. Mold it, shape it, and dance in it – make this space your own! Network Nirvana. Join a community of thinkers, leaders, and occasional coffee-sharing who are all on the path to greatness. 👥 Limited Edition! This isn’t a drill people, spaces like this don’t come by often and they don’t stay free for long. It’s time to level up your workplace vibe and get your team into something stellar. And 2 wonderful partners are on board: Q4BS GmbH and The Social Mall - Center for Social Quality Impact 📞 Ready to claim your space in our new corporate paradise? Hit us up at [email protected] and let’s chat about making magic happen in our new office! #Sustainable #Campus! 🎈 #OfficeSpace #Workspace #ModernOffice #BusinessOpportunity #OfficeForRent #ProfessionalSpace #CollaborationSpace

3

2 commentaires

🔍 France's Medtech sector is at a pivotal moment...In 2023, financial sponsor exits in French healthcare totaled just €141M compared to €1.3B in Germany and €8.1B in the US! Despite its rich history in medical innovation, the lack of local private equity investment is holding back promising companies. France currently accounts for 14% of the European medical device market but lags behind Germany’s 27%. The good news? There’s a backlog of mature French medtech firms generating revenues of €20M to €30M that are ready to scale up, but they need more local growth capital. Upcoming deals, such as Astorg’s stake in Echosens and Theravia’s exit pipeline, highlight the potential waiting to be unlocked. With the new European Commission expected to simplify regulations, the question remains: how can we harness PE support to ensure France's medtech sector thrives? Source : ION Analytics, Med Tech Europe #Healthcare #Medtech #Privateequity #Investments #France ——— I am Alexis - French pharmacist turned entrepreneur. My company BTHT is connecting senior industry experts, ex-payors, and KOLs with consultants and investors in Life Sciences and Healthcare for expert calls and senior advisory. Join 16K+ followers by clicking my name + follow 🔔 Join 1.4K+ subs to my weekly newsletter 💌

19

Value-based healthcare reform in the US and Europe by Elissa S., Independent Consultant, France 🇫🇷 What do you see as the main differences between the US and European healthcare systems? I moved to France from the United States in 2018 following reforms by the French government to incentivize value-based experimentation, and began working on consulting projects related to this initiative and value-based reform across Europe. Early on, I was struck by the different approaches between the United States and Europe. Value in healthcare is the quality of the outcomes of care relative to the cost of achieving those outcomes. While the United States places heavy emphasis on cost-control reforms (the denominator), Europe currently is much more focused on reforms that will improve quality (the numerator). There is a distinct set of priorities in each geographic region, and programs are taking off in other parts of the world as well. Unfortunately, what I see is that these reforms are happening mostly in silos. There is not enough effort or opportunity to exchange and learn from each other and share best practices. Of course there is so much that is particular and unique to each country, but that doesn’t mean that there isn’t a lot to be gained by evaluating the experiences of others as well. More needs to be done to create avenues to understand international approaches. This is one of the main reasons I launched Value Intelligence online courses through the Udemy platform. My first published course, Introduction to Value Based Healthcare, discusses value-based healthcare reforms in the US and Sweden, and the utility of each. It also introduces some of the basic structures and terminology and looks at value-based approaches in all of the different corners of the healthcare ecosystem... To access the full article, to continue reading onscreen or to download: https://lnkd.in/egihdctE This article was first published in EXPRESS, the eZINE of the Entrepreneurial Mindset Network, Volume 6 Number 2.

2

Digital Health in France: A Snapshot Over a year after #telemonitoring was officially integrated into France's healthcare system, the digital health market is beginning to take shape. While telemonitoring is making headway, particularly in oncology, digital therapies (#DTx) are struggling to gain a foothold. ✅ Telemonitoring Leading the Way, DTx Lagging Behind France has made notable progress in telemonitoring, with systems like Resilience Pro seeing success, especially in oncology. However, DTx is still facing significant challenges. The sluggish pace is primarily due to stringent requirements for clinical and organizational benefits, coupled with the government’s public health priorities, which tend to favour oncology and mental health (like depression and anxiety) while leaving areas like rehabilitation and chronic disease management behind. ✅ Market Trends: Where Digital Health is Gaining Ground ✔ Telemonitoring Gains Momentum in Oncology: Since June 2023, telemonitoring devices have been reimbursed under the general health coverage system, with cancer monitoring tools showing strong progress (1890 health structures have declared a remote monitoring activity so far). ✔ DTx Adoption Slow: Despite the rise of digital therapies in Europe, France lags behind countries like Germany. Hannes Klöpper has recently posted valuable insight about HelloBetter's struggle to secure reimbursement from Cnedimts. ✅ France vs. Germany France’s strict regulatory landscape contrasts sharply with Germany’s more flexible DiGA program, which allows faster reimbursement for digital health applications. Germany’s approach has fostered a broad range of innovative solutions, while France’s focus remains on specific areas like oncology. This explains why Germany is ahead in DTx adoption. ✅ Navigating the French Market: Key Insights and some advise ✔ Tackle Regulatory Hurdles Head-On: Be ready for a rigorous approval process, particularly for DTx. Early engagement with French authorities and collaboration with local players will definitely help navigate this complex landscape. I would recommend an upfront check-up of your « Market Access Readiness ». Spending that time is gaining a better view on your winning strategy and evaluating your chances more efficiently. ✔ Align with Priority Areas: Products targeting government-prioritized areas like oncology and mental health are more likely to succeed. Keep an eye on evolving health priorities to position your offerings strategically. ✔ Leverage Partnerships and Pilots: Forge alliances with influent French stakeholders and participate in pilot projects like “Article 51” to enhance market entry and boost approval chances. ✔ Plan for Financial Challenges: The path to market in France is costly and time-consuming. Explore alternative business models, such as direct-to-patient sales or partnerships with private insurers, to offset upfront costs.

2

🏥[#INFO] Spotlight on Healthcare Clusters in North America! Discover a snapshot of the main healthcare hubs in North America, their specific features as well as the key figures that justify the attractiveness and dynamism of the sector in the region. 💡Focus on the following regions: San Francisco Bay Area, Boston area, New York, Houston, Montreal and Toronto. 🌐 French MedTech and E-Health companies are increasingly venturing into North America, attracted by the burgeoning innovation and opportunities in this market. 🏆France, at the forefront of research and development, is coming out on top, so much so that the US has become the number one importer of French HealthTech. Americans are particularly interested in the excellence of French researchers and coders, as well as the quality of their algorithms. Explore the transformative French-American connections shaping the North American healthcare landscape. 🚀 French Healthcare

37

3 commentaires

#EUnetCCC | The French National Authority of Health (HAS), is proud to be one of the EUnetCCC leading partners, together with 31 countries, joining forces and connecting energies to develop the European Network of Comprehensive Cancer Centers. The HAS is committed to develop an innovative European certification scheme through intense cooperation with its partners: Unicancer, Fédération hospitalière de France (FHF), Institut national du cancer, Alleanza Contro il Cancro, Oslo universitetssykehus, Institut Català d'Oncologia (ICO), Deutsche Krebsgesellschaft e. V. (DKG), Technische Universität Dresden, NIZP PZH-PIB, Uniwersytet Ekonomiczny we Wrocławiu, VUL Santaros klinikos. 𝐖𝐡𝐚𝐭 𝐟𝐨𝐫? - Improving equal access to high-quality cancer care for all citizens in Europe. - Building a European Network of Comprehensive Cancer Centers will allow European citizens, whoever they are, wherever they live, to access the best cancer care Europeans all together can provide. If you want to know how the HAS will address the challenge 👇 | Lionel Collet Amelie Lansiaux Patrick Méchain Mona Krichen Sophie ALBERT Muriel Santoro European Health and Digital Executive Agency (HaDEA) Thomas Dubois Romain Mignerat Vincent Ollivier Xavier Troussard #EU4Health #CancerCare

44

2 commentaires

We previously discussed #QALYs in #HealthEconomicEvaluations ? But to calculate #QALYs, you need #utilities 😀 ! These are subjective values, and estimate the perception of #QualityOfLife at a certain point in time. This video describes the main methods to derive such estimates. #TTO #VAS #SG, #EQ5D, etc... these are key words you may have herd before. Wanna understand them better? Of note : all the links we share contain a summary PDF you can download, summarizing the video, so don't hesitate ! https://lnkd.in/e-7jxrfa

61

Looking forward to speaking at HLTH Europe tomorrow - the first European edition of the #1 healthcare event in the US! Along with 3 impressive panellists from the NHS, Doctolib and doctorly, as well as our moderator from Capgemini, we will discuss "rewriting the script" for Electronic Health Records. Join us tomorrow at 9:50 on the Aroma stage https://lnkd.in/dAj27pZg "Come on down and jump into the HLTH Europe time machine, as we head back to 1968. Humans are yet to set foot on the moon. The Beatles’ Hey Jude has just done a record nine weeks on the top of the charts. Charles de Gaulle is coming to the end of 10 years in power. Oh, and the first EHR has launched. Those first punch cards spawned an industry worth $28 billion today. We may have switched gears from the old problem-oriented records to subjective, objective, assessment, and plan (SOAP) notes, but even as the industry trundles along, the complete potential of EHRs remains a mystery for medical professionals, patients, and health systems. With more data available than ever before, functionality requests coming in faster than the industry can process, and ever-increasing demand on systems often built decades ago, how do we set the EHR straight?" #hlth #hltheurope #ehr #ai #healthcare Autoscriber LUMO Labs Brabantse Ontwikkelings Maatschappij (BOM)

54

🧬 Latest Deals in Healthcare & Life Sciences 💼 💼 Extens has acquired a majority stake in Medicore, marking its first investment outside France, as part of its European expansion strategy, focusing on enhancing mental health solutions and EHRs for over 25,000 healthcare professionals. 💰 Kurma Partners has successfully closed €140m in its first closing of Biofund IV, aiming to raise a total of €250m by 2025 for innovative therapeutics investments. 💰 Healius has entered into a binding agreement to sell its Lumus Imaging subsidiary to Affinity Equity Partners for an enterprise value of A$965m (US$669m), enabling Healius to focus on its pathology strategy and enhance customer service and digital technologies. 🤝 Fondo Italiano d'Investimento SGR has invested €10m to acquire a minority stake in Intrauma, a developer of advanced orthopaedic medical devices, to support its growth targets and product expansion. 🇬🇧 Huma has acquired eConsult and launched Huma Workspace, aiming to create a comprehensive digital-first healthcare platform for the NHS. 💰 Asabys Partners has successfully closed its Sabadell Asabys Health Innovation Investments II Fund at €180m, surpassing its target of €150m, to invest in biopharma, medical devices, and digital health companies. 🔬 Bruker Corporation has acquired Dynamic Biosensors, enhancing its biophysical portfolio for biomolecular interaction analysis. 💼 Miura Partners has closed its fourth flagship fund, Miura Fund IV, at its hard cap of €475m, marking a total fundraising of €800m in 2024, with significant investments in family-owned businesses across healthcare, education, and other sectors 🩺 Mölnlycke Health Care has finalized its acquisition of PGF Industry Solutions, the Austrian manufacturer of Granudacyn wound cleansing and moistening solutions. Source : Investors in Healthcare ——— I am Alexis - French pharmacist turned entrepreneur. My company BTHT connects experts with consultants and investors in Life Sciences and Healthcare for expert calls and senior advisory. For more content like this 👇 Join 15K+ followers by clicking my name + follow 🔔 Join 1.4K+ subscribers to my weekly newsletter 💌

25

2 commentaires

Investment Idea: The Healthcare Industry - Driving Growth and Stability The healthcare sector remains resilient and rapidly expanding, driven by aging populations and rising chronic diseases. Global healthcare spending is growing, with innovations in personalised medicine, digital health, and biotechnologies pushing boundaries and positioning the sector for long-term growth. The U.S. healthcare market is highly attractive for investment due to its size, flexible pricing, and steady demand. As a non-cyclical sector, healthcare offers stability across economic cycles, making it resilient in downturns. With increasing healthcare needs, this demand is unlikely to wane, presenting strong growth opportunities for investors. Technological advancements in pharmaceuticals, biotech, and medical devices are transforming patient care and unlocking new revenue streams. Companies like GSK, Roche, and Merck are well-positioned to capitalize on these trends. Demographic shifts, such as the global aging population, reinforce the sector’s robust long-term outlook. Healthcare stocks are traditionally viewed as defensive, offering stability in volatile markets. GSK, Roche, and Merck have a proven track record of weathering economic storms. For the proposed note offering a 10% coupon, the S&P 500 would have to statistically experience an unprecedented 56% drop before breaching the proposed barrier level of the product —underscoring healthcare’s strength as a reliable investment in uncertain times. If you wish to gain access to the full presentation of the idea, do not hesitate to contact our team: Romain Duchenne: [email protected] Hugo Poupinel: [email protected] For more information on our company, please access the website below: https://lnkd.in/eFBWjTG4

7

🧑‍⚕️ 'Our home #nurses exchange information about #patients and make mutual decisions via Doctolib Siilo. It is crucial that they can communicate with each other securely, especially as we handle sensitive information subject to #GDPR legislation', says Julie Vanhoof, Business Unit Manager at OptiCare Thuisverpleging. Read the full interview with Julie about the use of Doctolib Siilo within their organisation (article in Dutch 🇳🇱🇧🇪) >> https://ow.ly/gwIL50RQyoJ #healthcare #ehealth #medicine #gezondheidszorg #zorg

19

3 commentaires